amgen (biotechcompany)
literal strings:
Amgen, AMGEN, amgen
amgen inc, Amgen Inc, AMGEN INC
Amgen Inc.
Help NELL Learn!
NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.
categories
- biotechcompany(100.0%)
- SEAL @210 (100.0%) on 15-feb-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 ] using amgen
- CPL @1108 (65.2%) on 06-jun-2018 [ "_ has asked the FDA" "biotech companies like _" "drug discovery collaboration with _" "_ sells the drug" "independent educational grant from _" "medication produced by _" "collaboration agreement with _" "milestone payments from _" "pharmaceutical giants such as _" "drugs are manufactured by _" "Information Scientist at _" "_ has obtained an option" "Technologies group at _" "research support from _" "grant support from _" "_ beat the mean analyst estimate" "_ is a biotechnology company" "class action accusing _" "drug discovery at _" "biotechnology companies such as _" "study was sponsored by _" "molecule developed by _" "biotech companies such as _" "biotechnology companies , including _" "process engineer at _" "Corp. , acquired by _" "co-markets with _" "_ 's corporate philanthropy" "biotech companies , including _" "experimental drug from _" "drugs made by _" "drug , made by _" "drug made by _" "major pharmaceutical companies , including _" "unrestricted educational grant from _" "unrestricted research grant from _" "medical affairs for _" "biotech companies , such as _" "seasonal patterns for _" "drug companies such as _" "_ 's Neupogen" "drug sold by _" "grant/research support from _" "pharmaceutical companies such as _" "educational grant from _" "unrestricted grant from _" "pharmaceutical companies , including _" "Pharma companies like _" "senior process engineer at _" "_ 's Enbrel" "_ is a pharmaceutical company" "discovery collaboration with _" "Large employers such as _" "educational grants from _" ] using amgen_inc_
- CPL @1109 (57.2%) on 12-jun-2018 [ "collaboration deal with _" "grant/research support from _" "speakers bureau for _" "educational grants from _" "drugmakers such as _" "drugs manufactured by _" "drug is manufactured by _" "research support from _" "biotech giant _" "_ 's Enbrel" "Whales playing _" ] using amgen_inc
- CMC @542 (100.0%) on 29-mar-2012 [ LASTPREFIX=in 2.48673 LASTSUFFIX=nc 2.45451 LAST_WORD=inc 2.41015 SUFFIX=nc 2.39856 PREFIX=in 1.63711 SUFFIX=gen 1.43704 PREFIX=am 1.24165 FULL_POS=NN_NN -0.77955 SHORT_WORDSHAPE=a -1.45269 WORDS -2.66939 ] using amgen_inc
- CMC @1105 (100.0%) on 25-mar-2018 [ SUFFIX=gen 3.45957 LASTSUFFIX=gen 3.10342 LASTPREFIX=amge 1.80632 LASTPREFIX=amg 1.80513 PREFIX=am 1.77198 PREFIX=amge 1.75712 PREFIX=amg 1.74096 FULL_WORDSHAPE=A -0.74259 FULL_POS=NN -1.07808 WORDS -1.11877 ] using amgen
- CPL @1098 (70.5%) on 21-jan-2018 [ "honoraria received from _" "Major employers such as _" "pharma companies such as _" "company later acquired by _" "drug , marketed by _" "_ is a biotech company" "drug sold by _" "_ 's new drug" "drug produced by _" "_ 's global locations" "international companies like _" "upfront cash payment to _" "speaker bureau for _" "medical device companies including _" "Inc was acquired by _" "_ 's experimental drug" "_ asks FDA" "top companies , including _" "sciences companies such as _" "medication you purchase is manufactured by _" "_ was granted an exclusive license" "trial was sponsored by _" "therapeutic areas at _" "leading companies as _" "global marketing at _" "speakers bureaus of _" "consultation fees from _" "drug companies such as _" "clinical research from _" "research operations at _" "biotechnology companies like _" "clinical scientist at _" "drug manufactured by _" "unofficial affiliation with _" "honorarium from _" "Pharmaceutical companies like _" "lower-cost hedged play for _" "assistance program provided by _" "biotech firms such as _" "donation provided by _" "investigator-initiated grant from _" "_ is a global biotechnology company" "_ immediately cease the dissemination" "_ 's Canadian affiliate" "grant donated by _" "educational grants from _" "_ is a pharmaceutical company" "top holdings are _" "unrestricted grants from _" "consultant fees from _" "educational grant provided by _" "discovery collaboration with _" "trial , sponsored by _" "study was sponsored by _" "biotech firms like _" "national players like _" "_ 's BLA" "Chemistry department at _" "Key players covered include _" "Credit Suisse upgraded _" "established companies such as _" "experimental drug from _" "_ 's periodic reports" "It is marketed by _" "_ 's principal executive offices" "infringement lawsuit brought by _" "medications manufactured by _" "medicinal chemist at _" "grants/research support from _" "consultancy fees from _" "major financial trends at _" "unrestricted educational grant by _" "trial sponsored by _" "_ 's manufacturing site" "Technologies group at _" "biotech firms , including _" "FDA asked _" "_ 's Japanese affiliate" "_ 's new treatment" "Bear Stearns upgraded _" "drug discovery collaboration with _" "first marketed by _" "rival drug from _" "drugmakers , including _" "several biotechnology companies , including _" "speaker honoraria from _" "science companies including _" "company acquired by _" "device companies including _" "biotech company called _" "biotechs like _" "discovery efforts at _" "educational grants provided by _" "drug developed by _" "_ dropped the drug" "grant/research support from _" "speakers bureau for _" "historical stock prices for _" "_ 's corporate philanthropy" "_ provide an intern" "generous educational grant from _" "biotech companies including _" "biotechnology company called _" "co-markets with _" "biotech giants like _" "It is manufactured by _" "biotechnology companies such as _" "Regulatory Affairs department at _" "_ 's financial guidance" "_ distributes this drug" "grant support from _" "drug metabolism at _" "you purchase is manufactured by _" "_ also holds the patent" "studies , conducted by _" "drug discovery efforts at _" "drug makers like _" "_ has obtained an option" "pharmaceutical manufacturers such as _" "news developments at _" "patent infringement lawsuit brought by _" "biopharmaceutical companies such as _" "_ 's U.S. Patent Nos" "drug discovery at _" "drugs are manufactured by _" "speakers bureaus for _" "healthcare companies such as _" "_ is a biotechnology firm" "clinical trial sponsored by _" "_ announced FDA approval" "_ 's osteoporosis drug" "_ obtained an option" "_ 's Japanese subsidiary" "supplement was funded by _" "immunology research at _" "computational scientist at _" "biotechnology companies including _" "_ 's drug development programs" "_ 's DIFLUCAN" "consulting fees from _" "U.S. firms such as _" "Training Manager at _" "pharmaceutical firms such as _" "FDA required _" "biotech companies like _" "unrestricted educational grant from _" "major pharmaceutical companies such as _" "life science companies including _" "sales last year for _" "research support from _" "rich corporations like _" "growth companies such as _" "unrestricted research grant from _" "unrestricted educational grant provided by _" "patient assistance program provided by _" "_ withdrew the drug" "speakersbureau for _" "_ developed the drug" "clinical development at _" "co-development agreement with _" "biotech companies , such as _" "drug companies , including _" "drug being developed by _" "educational donation provided by _" "drug makers such as _" "milestone payment from _" "recent news developments at _" "treatment sold by _" "affairs positions at _" "biotech giant _" "hedged play for _" "speaking fees from _" "milestone payments from _" "key clients included _" "_ Is Pfizer" "_ 's registered trademark" "_ 's corporate mission" "major pharmaceutical companies including _" "industry powerhouses such as _" "chief medical officer at _" "grant is sponsored by _" "large pharmaceutical companies such as _" "biotechnology companies , including _" "biotech companies such as _" "global companies including _" "honoraria from _" "tender offer has advised _" "major corporations such as _" "such leading companies as _" "medical affairs for _" "players covered include _" "medication marketed by _" "_ is seeking FDA approval" "_ makes a drug" "_ 's Japanese unit" "drugs made by _" "discovery research at _" "drug development at _" "principal engineer at _" "quality engineer at _" "_ 's patient assistance program" "_ also receives royalties" "_ 's European headquarters" "Pharmaceutical companies such as _" "enrollment form available please call _" "booster made by _" "offer has advised _" "unrestricted grant from _" "research grant support from _" "Key market players covered are _" "_ says FDA" "drug is manufactured by _" "drug is made by _" "drug , manufactured by _" "drug companies including _" "Planning group at _" "_ 's Neupogen" "educational grant by _" "educational grant from _" "research grant funding from _" "antibody developed by _" "form available please call _" "trial was funded by _" "_ 's first-quarter profit" "market players covered are _" "_ acquired exclusive worldwide rights" "_ 's Enbrel" "_ 's development pipeline" "_ 's experimental drugs" "joint development program with _" "biotech companies , including _" "collaboration agreement with _" "development areas at _" "_ informed FDA" "several industry leaders , including _" "drug was developed by _" "_ 's therapeutic areas" "unrestricted educational grants from _" "_ is asking the FDA" "pharmaceutical companies including _" "pharmaceutical companies , such as _" "patent infringement action against _" "_ 's pipeline products" "International companies such as _" "_ is a biotechnology company" "new drug developed by _" "_ 's U.S. Patent No." "_ is seeking products" "_ has the worldwide rights" "_ is a large pharmaceutical company" "_ has worldwide rights" "_ hopes the drug" "_ has asked the FDA" "pharma companies like _" "financial trends at _" "drug made by _" "drug , made by _" "Biotech companies like _" "lecture fees from _" "various pharmaceutical companies , including _" "biopharmaceutical companies including _" "biopharmaceutical companies , including _" "Strategy group at _" "_ 's World Headquarters" "_ 's product candidates" "patent portfolio from _" "biotechnology companies , such as _" "pharmaceutical companies , including _" "pharmaceutical companies like _" "process development at _" "several pharmaceutical companies , including _" "drug companies like _" "patent held by _" "global leaders such as _" "stimulator from _" "Suisse upgraded _" "_ 's blockbuster drug" "_ 's patent position" "players covered are _" "pharmaceutical companies such as _" "_ 's NITROFURANTOIN" "Major corporations include _" "_ 's original patent" "outcomes research at _" "Stearns upgraded _" "consulting job with _" ] using amgen
- Human feedback from estevam @888 on 02-dec-2014 [ "amgen generalizations company", Action=(+biotechcompany) (from NELL.08m.888.SSFeedback.csv) ] using amgen
- OE @892 (86.2%) on 26-dec-2014 [ http://wwwext.amgen.com/about/amgen.html http://www.bloomberg.com/quote/AMGN:US http://en.wikipedia.org/wiki/Amgen http://wwwext.amgen.com/about/amgen.html http://www.washington.edu/research/urp/amgen/ https://students.ucsd.edu/academics/research/amgen/ https://students.ucsd.edu/academics/research/amgen/ http://wwwext.amgen.com/about/amgen.html http://wwwext.amgen.com/about/amgen.html http://en.wikipedia.org/wiki/Amgen http://www.washington.edu/research/urp/amgen/ http://www.amgenscholars.com/ http://wwwext.amgen.com/about/amgen.html http://careers.amgen.com/ https://twitter.com/Amgen http://en.wikipedia.org/wiki/Amgen https://students.ucsd.edu/academics/research/amgen/ https://students.ucsd.edu/academics/research/amgen/ ] using amgen
- SEAL @241 (99.8%) on 22-apr-2011 [ 1 2 3 4 5 6 7 8 9 ] using amgen_inc
- OE @883 (86.1%) on 30-oct-2014 [ http://www.bloomberg.com/quote/AMGN:US https://finance.yahoo.com/q/pr?s=AMGN http://www.google.com/finance?cid=18784 http://www.google.com/finance?cid=18784 http://finance.yahoo.com/q?s=AMGN https://finance.yahoo.com/q/pr?s=AMGN http://www.google.com/finance?cid=18784 http://www.google.com/finance?cid=18784 http://www.drugs.com/manufacturer/amgen-inc-18.html http://www.scotusblog.com/case-files/cases/amgen-inc-v-connecticut-retirement-plans-and-trust-funds/ http://www.amgenassist.com/ https://finance.yahoo.com/q/pr?s=AMGN http://www.nasdaq.com/symbol/amgn http://www.google.com/finance?cid=18784 http://careers.amgen.com/ http://www.drugs.com/manufacturer/amgen-inc-18.html https://finance.yahoo.com/q/pr?s=AMGN ] using amgen_inc
- company(100.0%)
NELL has only weak evidence for items listed in grey
- retailstore
- SEAL @799 (54.0%) on 21-dec-2013 [ 1 2 ] using amgen_inc
- SEAL @730 (62.3%) on 02-may-2013 [ 1 ] using amgen
relations
- acquired
- immunex (93.8%)
- CPL @1095 (93.8%) on 17-jan-2018 [ "arg2 was acquired by arg1" "arg2 was purchased by arg1" "arg2 Corporation and later arg1" "arg2 on its sale to arg1" ] using (amgen, immunex)
- agentcollaborateswithagent
- kevin_w__sharer (100.0%)
- SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (amgen, kevin_w__sharer)
- SEAL @458 (50.0%) on 23-nov-2011 [ 1 ] using (kevin_w__sharer, amgen)
- gordon_binder (93.8%)
- CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 chairman arg2" "arg1 Chairman and CEO arg2" ] using (amgen, gordon_binder)
- CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 chairman arg2" "arg1 Chairman and CEO arg2" ] using (gordon_binder, amgen)
- gordon_binder (93.8%)
- CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 chairman arg2" "arg1 Chairman and CEO arg2" ] using (amgen, gordon_binder)
- CPL @1098 (75.0%) on 21-jan-2018 [ "arg1 chairman arg2" "arg1 Chairman and CEO arg2" ] using (gordon_binder, amgen)
- agentcontrols
- kevin_w__sharer (100.0%)
- SEAL @331 (99.9%) on 03-jul-2011 [ 1 2 3 4 5 6 7 8 9 10 ] using (amgen, kevin_w__sharer)
- OE @809 (100.0%) on 01-feb-2014 [ ] using (amgen, kevin_w__sharer)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:agentcollaborateswithagent" "Y~_X0~concept:agentinteractswithagent" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:superpartof" "Y~X0~concept:agentcollaborateswithagent" ] using (amgen, kevin_w__sharer)
- agentworkedondrug
- aranesp (100.0%)
- OE @823 (85.9%) on 17-mar-2014 [ ] using (aranesp, amgen)
- SEAL @213 (99.2%) on 21-feb-2011 [ 1 2 3 4 5 6 7 ] using (aranesp, amgen)
- CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 Epogen and arg1" "arg2 to add a warning to arg1" "arg2 the maker of arg1" ] using (aranesp, amgen)
- SEAL @236 (50.0%) on 16-apr-2011 [ 1 ] using (aranesp, amgen_inc)
- neupogen (99.2%)
- SEAL @236 (50.0%) on 16-apr-2011 [ 1 ] using (neupogen, amgen_inc)
- SEAL @269 (98.4%) on 24-may-2011 [ 1 2 3 4 5 6 ] using (neupogen, amgen)
- neulasta (98.4%)
- SEAL @213 (98.4%) on 21-feb-2011 [ 1 2 3 4 5 6 ] using (neulasta, amgen)
- epogen (93.8%)
- SEAL @213 (75.0%) on 21-feb-2011 [ 1 2 ] using (epogen, amgen)
- CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 began marketing arg1" "arg2 sells under the brand name arg1" ] using (epogen, amgen)
- nplate (93.8%)
- SEAL @213 (87.5%) on 21-feb-2011 [ 1 2 3 ] using (nplate, amgen)
- CPL @1103 (50.0%) on 06-mar-2018 [ "arg1 is manufactured by arg2" ] using (nplate, amgen)
- vectibix (93.8%)
- CPL @1103 (50.0%) on 06-mar-2018 [ "arg1 is manufactured by arg2" ] using (vectibix, amgen)
- SEAL @263 (87.5%) on 22-may-2011 [ 1 2 3 ] using (vectibix, amgen)
- companyeconomicsector
- controlledbyagent
- mutualproxyfor
- kevin_w__sharer (100.0%)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" "Y~X0~concept:controlledbyagent,concept:mutualproxyfor,concept:controlledbyagent" ] using (kevin_w__sharer, amgen)
- SEAL @566 (87.5%) on 12-may-2012 [ 1 2 3 ] using (amgen, kevin_w__sharer)
- OE @962 (100.0%) on 05-dec-2015 [ http://articles.latimes.com/2011/dec/16/business/la-fi-amgen-ceo-20111216 http://articles.latimes.com/keyword/kevin-sharer http://articles.latimes.com/keyword/kevin-sharer ] using (kevin_w__sharer, amgen)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" "Y~X0~concept:controlledbyagent,concept:mutualproxyfor,concept:controlledbyagent" ] using (amgen, kevin_w__sharer)
- OE @962 (100.0%) on 05-dec-2015 [ http://articles.latimes.com/2011/dec/16/business/la-fi-amgen-ceo-20111216 http://articles.latimes.com/keyword/kevin-sharer http://articles.latimes.com/keyword/kevin-sharer ] using (amgen, kevin_w__sharer)
- SEAL @566 (87.5%) on 12-may-2012 [ 1 2 3 ] using (kevin_w__sharer, amgen)
- kevin_w__sharer (100.0%)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" "Y~X0~concept:controlledbyagent,concept:mutualproxyfor,concept:controlledbyagent" ] using (kevin_w__sharer, amgen)
- SEAL @566 (87.5%) on 12-may-2012 [ 1 2 3 ] using (amgen, kevin_w__sharer)
- OE @962 (100.0%) on 05-dec-2015 [ http://articles.latimes.com/2011/dec/16/business/la-fi-amgen-ceo-20111216 http://articles.latimes.com/keyword/kevin-sharer http://articles.latimes.com/keyword/kevin-sharer ] using (kevin_w__sharer, amgen)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:superpartof" "Y~_X0~concept:superpartof,concept:subpartof,concept:superpartof" "Y~X0~concept:controlledbyagent" "Y~_X0~concept:agentcontrols" "Y~X0~concept:controlledbyagent,concept:mutualproxyfor,concept:controlledbyagent" ] using (amgen, kevin_w__sharer)
- OE @962 (100.0%) on 05-dec-2015 [ http://articles.latimes.com/2011/dec/16/business/la-fi-amgen-ceo-20111216 http://articles.latimes.com/keyword/kevin-sharer http://articles.latimes.com/keyword/kevin-sharer ] using (amgen, kevin_w__sharer)
- SEAL @566 (87.5%) on 12-may-2012 [ 1 2 3 ] using (kevin_w__sharer, amgen)
- organizationhasperson
- organizationleadbyperson
- kevin_w__sharer (100.0%)
- SEAL @185 (99.8%) on 06-jan-2011 [ 1 2 3 4 5 6 7 8 9 ] using (kevin_w__sharer, amgen)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~_X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyperson,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:organizationleadbyagent,concept:personbelongstoorganization" "Y~X0~concept:personbelongstoorganization,concept:proxyof,concept:personbelongstoorganization" ] using (kevin_w__sharer, amgen)
- OE @809 (100.0%) on 01-feb-2014 [ ] using (kevin_w__sharer, amgen)
- organizationterminatedperson
- kevin_w__sharer (100.0%)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:organizationleadbyagent,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:proxyof,concept:worksfor,concept:organizationleadbyperson" "Y~X0~concept:proxyof,concept:subpartof,concept:organizationhasperson" "Y~X0~concept:proxyof,concept:subpartof,concept:worker" "Y~X0~concept:organizationleadbyagent,concept:worksfor,concept:controlledbyagent" ] using (amgen, kevin_w__sharer)
- proxyof
- kevin_w__sharer (93.8%)
- SEAL @551 (93.8%) on 10-apr-2012 [ 1 2 3 4 ] using (kevin_w__sharer, amgen)
- worker
- kevin_w__sharer (100.0%)
- PRA @960 (100.0%) on 10-nov-2015 [ "Y~X0~concept:personleadsorganization,concept:worker,concept:agentleadsorganization" "Y~_X0~concept:agentleadsorganization" "Y~_X0~concept:agentrepresentsorganization" "Y~_X0~concept:personleadsorganization" "Y~_X0~concept:agentcontrols" ] using (kevin_w__sharer, amgen)
- SEAL @521 (93.8%) on 28-feb-2012 [ 1 2 3 4 ] using (kevin_w__sharer, amgen)
NELL has only weak evidence for items listed in grey
- acquired
- abgenix
- CPL @1096 (75.0%) on 18-jan-2018 [ "arg1 via its acquisition of arg2" "arg1 acquired arg2" ] using (amgen, abgenix)
- johnson___johnson (biotechcompany)
- CPL @1107 (50.0%) on 24-may-2018 [ "arg1 but licensed to arg2" ] using (amgen, johnson___johnson)
- agentworkedondrug
- feraheme
- SEAL @607 (50.0%) on 04-jul-2012 [ 1 ] using (feraheme, amgen)
- procrit
- CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (procrit, amgen)
- acquired
- ilypsa
- CPL @1095 (87.5%) on 17-jan-2018 [ "arg1 acquired arg2" "arg1 bought out arg2" "arg1 to Acquire arg2" ] using (amgen, ilypsa)
- johnson___johnson (product)
- CPL @1107 (50.0%) on 24-may-2018 [ "arg1 but licensed to arg2" ] using (amgen, johnson___johnson)
- agentcontrols
- gordon_binder
- CPL @1100 (75.0%) on 31-jan-2018 [ "arg1 chairman arg2" "arg1 Chairman and CEO arg2" ] using (amgen, gordon_binder)
- companyeconomicsector
- mutualproxyfor
- gordon_binder
- CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 chairman arg2" ] using (amgen, gordon_binder)
- CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 chairman arg2" ] using (gordon_binder, amgen)
